The US FDA has granted marketing authorization to the PMD-200 monitor developed by Israel’s Medasense Biometrics (see here previously). The device monitors pain in non-communicating (e.g., anaesthetized) patients and already has made an impact in multiple countries.
US approves pain-monitoring device
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.